EUVIMEDEUVIMED entdecken
Vergleichsstudie

Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer with [ 68 Ga]Ga-FAPI-04 PET, [ 18 F]FDG PET, and Contrast-Enhanced MRI: Lesion-to-Lesion Comparison with Pathology

Xiao Zhang, Zhenyu Lin, Yuan Feng, Zhaoguo Lin, Kaixiong Tao, Tao Zhang, Xiaoli Lan

Journal of Nuclear Medicine · 2024-10 · 65 (10) · 1548-1556

DOI: 10.2967/jnumed.124.267581 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 01.10.2024. Verfasst von Xiao Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Rectal Neoplasms, Fluorodeoxyglucose F18, Magnetic Resonance Imaging, Contrast Media. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neoadjuvant therapy in patients with locally advanced rectal cancer (LARC) has achieved good pathologic complete response (pCR) rates, potentially eliminating the need for surgical intervention. This study investigated preoperative methods for predicting pCR after neoadjuvant short-course radiotherapy (SCRT) combined with immunochemotherapy.

Methods

Treatment-naïve patients with histologically confirmed LARC were enrolled from February 2023 to July 2023. Before surgery, the patients received neoadjuvant SCRT followed by 2 cycles of capecitabine and oxaliplatin plus camrelizumab. 68Ga-labeled fibroblast activation protein inhibitor ([68Ga]Ga-FAPI-04) PET/MRI, [18F]FDG PET/CT, and contrast-enhanced MRI were performed before treatment initiation and before surgery in each patient. PET and MRI features and the size and number of lesions were also collected from each scan. Each parameter's sensitivity, specificity, and diagnostic cutoff were derived via receiver-operating-characteristic curve analysis.

Results

Twenty eligible patients (13 men, 7 women; mean age, 60.2 y) were enrolled and completed the entire trial, and all patients had proficient mismatch repair or microsatellite-stable LARC. A postoperative pCR was achieved in 9 patients (45.0%). In the visual evaluation, both [68Ga]Ga-FAPI-04 PET/MRI and [18F]FDG PET/CT were limited to forecasting pCR. Contrast-enhanced MRI had a low sensitivity of 55.56% to predict pCR. In the quantitative evaluation, [68Ga]Ga-FAPI-04 change in SULpeak percentage, where SULpeak is SUVpeak standardized by lean body mass, had the largest area under the curve (0.929) with high specificity (sensitivity, 77.78%; specificity, 100.0%; cutoff, 63.92%). Conclusion: [68Ga]Ga-FAPI-04 PET/MRI is a promising imaging modality for predicting pCR after SCRT combined with immunochemotherapy. The SULpeak decrease exceeding 63.92% may provide valuable guidance in selecting patients who can forgo surgery after neoadjuvant therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsFluorodeoxyglucose F18Magnetic Resonance ImagingContrast MediaHumansFemaleMaleMiddle AgedAgedPositron-Emission TomographyTreatment OutcomeNeoadjuvant TherapyAdultPositron Emission Tomography Computed TomographyPathologic Complete ResponseQuinolines

Stichwörter der Autor:innen

[68Ga]Ga-FAPI-04colorectal cancerimmunotherapypathologic complete response

Substanzen

Fluorodeoxyglucose F18Contrast Media68Ga-FAPIQuinolines

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hubei Key Laboratory of Molecular Imaging, Wuhan, China.
  • Key Laboratory of Biological Targeted Therapy, Ministry of Education, Wuhan, China.
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; and.
  • Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; and taozhangxh@hust.edu.cn lxl730724@hotmail.com.

Zitieren

APA

Zhang, X., Lin, Z., Feng, Y., Lin, Z., Tao, K., Zhang, T., & Lan, X. (2024). Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer with [ 68 Ga]Ga-FAPI-04 PET, [ 18 F]FDG PET, and Contrast-Enhanced MRI: Lesion-to-Lesion Comparison with Pathology. Journal of Nuclear Medicine, 65(10), 1548-1556. https://doi.org/10.2967/jnumed.124.267581

Vancouver

Zhang X, Lin Z, Feng Y, Lin Z, Tao K, Zhang T, et al. Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer with [ 68 Ga]Ga-FAPI-04 PET, [ 18 F]FDG PET, and Contrast-Enhanced MRI: Lesion-to-Lesion Comparison with Pathology. Journal of Nuclear Medicine. 2024;65(10):1548-1556. doi:10.2967/jnumed.124.267581

BibTeX
@article{Zhang2024,
  author = {Zhang, Xiao and Lin, Zhenyu and Feng, Yuan and Lin, Zhaoguo and Tao, Kaixiong and Zhang, Tao and Lan, Xiaoli},
  title = {Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer with [ 68 Ga]Ga-FAPI-04 PET, [ 18 F]FDG PET, and Contrast-Enhanced MRI: Lesion-to-Lesion Comparison with Pathology},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  volume = {65},
  number = {10},
  pages = {1548--1556},
  doi = {10.2967/jnumed.124.267581}
}
Kostenlos starten →